LID.L Regulatory News (LID)

13 Jan 2009 07:00



LiDCO Group Plc

("LiDCO" or the "Company")

Further Distribution Expansion

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, is pleased to announce further expansion of its distribution network. An exclusive distribution agreement has been signed for the sale of LiDCOrapid Monitor and disposables in Australia and New Zealand with Neomedix Systems based in Sydney. 

Neomedix Systems has been a supplier to the medical community of Australia for over 30 years and is a successful importer/distributor of medical equipment, including high-end bedside patient monitoring and cardiac investigation products. Australia's high per capita income and spending on healthcare at 9.7 percent of GDP creates a demand for sophisticated medical equipment whose use can result in a significant improvement in clinical outcomes.

Dr Terry O'Brien, CEO LiDCO Group plc, commented:  "Worldwide we estimate that surgical hemodynamic monitoring represents a potential annual revenue opportunity of over $800 million.  Our strategy has been to significantly expand our access to this market opportunity through 3rd party distributors. This appointment is a useful addition to our growing route to market. Over the last year, including Neomedix, we have added distributors in a total of 10 new territories:  USA (eastern half), Russia, Israel, Canada, Turkey, Middle East, Portugal, Bulgaria & Argentina.'

- ENDS - 

For more information please contact:

Media enquiries

About LiDCO Group Plc

LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus is a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%)

* LiDCOrapid: our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care. The monitor features many clinical benefits. These enable acute care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being during and after surgery. 

* LiDCO single patient use disposables used in conjunction with the LiDCOplus and LiDCOrapid Monitors. 

* LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase

* LiDCOlive: a software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus or LiDCOrapid monitors

LiDCO Distribution Network:

The Company sells direct in the UK, direct and elsewhere through a worldwide network of speciality critical care and anesthesia distributors.